The COVID-19 Airborne Threat
Protecting Patients & Staff in Healthcare Environments
COVID-19 is an airborne threat to patients & staff.
The LifeAire System is mathematically and genomically modeled to kill or inactivate the most infectious biological pathogens-including but not limited to anthrax spores, tuberculosis, COVID-19 (Coronavirus), and influenza-on a single pass through the system.
The LifeAire System was initially designed to protect the environment of the human embryo in the In Vitro Fertilization (IVF) laboratory. To achieve this, it was critical that the system remediate all chemical and biological contaminants from the air. Therefore, LifeAire was genomically and mathematically modeled to kill the anthrax spore, the most difficult biological spore to kill.
Because of its effectiveness towards the anthrax spore, the LifeAire System is able to provide a 9-log* reduction of all infectious airborne bacterial, viral and fungal pathogens. Airborne bacterial, fungal and viral pathogens represent a consistent threat to both the IVF and healthcare environment.
LifeAire will deliver a kill/disinfection rate of 145-log** against the airborne COVID-19 virus. As reference, sterility is defined by a 6-log*** reduction. The susceptibility to germicidal kill of any microorganism is determined by its genomic sequence of ACTG, and in particular, the recurrence of TT and TTT. The viral kill delivered by the LifeAire System provides a 145-log kill specific to the genomic sequence of the COVID-19 virus.
The kill mechanisms used in our system have been tested by the National Homeland Security Research Center. Our technology has received (26) U.S. and international patents to date.
* 9-log kill equals 1 X 10^9 remediation efficiency
** 145-log kill equals 1 X 10^145 remediation efficiency
*** 6-log kill equals 1 X 10^6 remediation efficiency